Fortitude Family Office’s Climb Bio CLYM Stock Holding History

Fortitude Family Office’s Portfolio CLYM Stock Details CLYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.05K	Hold	92	–	–	﹤0.01%	2233
2026 Q2	$1.2K	Hold	92	–	–	﹤0.01%	1685
2026 Q1	$630	Buy	+92	New	+$531	﹤0.01%	1638

Other funds holding CLYM

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office's CLYM Position: Q3 2026 in Review

Fortitude Family Office held its Climb Bio (CLYM) position steady in Q3 2026 at 92 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

Fortitude Family Office first reported a position in CLYM in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.2K in Q2 2026. 3 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

Fortitude Family Office held 92 shares of Climb Bio worth $1.05K as of Q3 2026.
Fortitude Family Office left its Climb Bio share count unchanged in Q3 2026.
Climb Bio made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2233 holding.
Fortitude Family Office first reported a position in Climb Bio in Q1 2026 and has held it in 3 quarters since.
Fortitude Family Office's Climb Bio position peaked at $1.2K in Q2 2026.
3 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.